• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

CAR T-Cell Therapy for the Management of Multiple Myeloma

home / insights / car-t-cell-therapy-for-the-management-of-multiple-myeloma

Oncologists explore the opportunity of CAR T-cell therapy for the treatment of relapsed/refractory multiple myeloma.

© 2024 MJH Life Sciences
All rights reserved.